SUBSTIPHARM

Substipharm is a privately held pharmaceutical group developing, supplying and commercializing more than 90 pharmaceutical products worldwide, with a pipeline of more than 40 ongoing projects. The company focuses on niche or differentiating products, based on technology and market size, which it either markets directly or licenses out to other pharmaceutical companies depending on the country, maintaining a successful portfolio of pharmaceutical products and dossiers including generics.